MeSH tree: D12.776.476.075
A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or ...
Feb 6, 2026
0
117
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Jan 13, 2026
0
21
The parasite that may already live in your brain can infect the very immune cells trying to destroy it, but new UVA Health research reveals how our bodies keep it under control.
Jan 7, 2026
0
23
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to chemotherapy. However, patients ...
Dec 23, 2025
0
44
A team of researchers, affiliated with UNIST, has identified a protein sensor that plays a key role in triggering severe inflammatory responses during mpox virus (MPXV) infection. The study reveals that this protein, known ...
Dec 15, 2025
0
10
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction ...
Oct 16, 2025
0
20
New insights into the mechanisms that cause more severe cases of schistosomiasis—a disease caused by parasitic worms and second only to malaria in terms of potential harm—have been revealed by researchers at Penn State.
Apr 16, 2025
0
39
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and treating atrial fibrillation, a condition that significantly raises the risks of stroke and dementia. ...
Feb 6, 2025
0
27
Brain injuries cause widespread damage to brain tissue. Damaged cells begin to produce signaling molecules that trigger processes of inflammation, apoptosis—programmed cell death—and oxidative stress. After the acute phase ...
Jan 18, 2024
0
44
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma, according ...
Sep 22, 2023
0
61
